Joseph A. Tyndall - 19 Jun 2025 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
/s/ Marc Began as attorney-in-fact for Joseph A. Tyndall
Issuer symbol
AXGN
Transactions as of
19 Jun 2025
Transactions value $
$0
Form type
4
Date filed
20 Jun 2025, 16:10
Previous filing
11 Jun 2025
Next filing
10 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
TYNDALL JOSEPH A. Director C/O AXOGEN, INC. 13631 PROGRESS BLVD.,, SUITE 400, ALACHUA /s/ Marc Began as attorney-in-fact for Joseph A. Tyndall 2025-06-20 0001955281

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Restricted Stock Units Award $0 +14.2K $0.00 14.2K 19 Jun 2025 Common Stock 14.2K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F2 Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date.